A Close Examination of Patient Experiences in Cluster Headache Clinical Research
Launched by POWER LIFE SCIENCES INC. · Jul 28, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand the experiences of people with cluster headaches who participate in research studies. Often, clinical trials attract certain groups of people more than others, so this study aims to find out why that is and how to make it easier for everyone, especially those who might not usually get involved, to participate in trials for cluster headache treatments.
To join the study, you need to be at least 18 years old and have been diagnosed with cluster headaches. You also need to have access to the internet so you can provide updates during the study. If you’re interested, you can expect to share your experiences and thoughts on what makes it easier or harder to participate in clinical trials. This information will be used to help improve future studies and ensure that all patients have a fair chance to access new treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient has been diagnosed with cluster headache
- • Patient has access to a home internet connection in order to provide regular updates through the course of the study
- • Participant must be 18 years of age or older
- Exclusion Criteria:
- • Patient has an ECOG score of 4 or higher
- • Patient is not able to provide consistent digital updates as per study requirements
- • Patient does not complete or agree to terms outlined in the Informed Consent Form
About Power Life Sciences Inc.
Power Life Sciences Inc. is a forward-thinking clinical trial sponsor dedicated to advancing innovative therapeutic solutions across various medical disciplines. With a strong emphasis on scientific rigor and patient-centered approaches, the organization collaborates with leading researchers and healthcare professionals to design and execute clinical trials that prioritize safety, efficacy, and compliance. Power Life Sciences Inc. leverages cutting-edge technology and data analytics to streamline trial processes, enhance participant engagement, and accelerate the development of life-changing treatments, ultimately aiming to improve patient outcomes and contribute to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Michael B Gill
Study Director
Power Life Sciences Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported